Document is current
Any future updates will be listed below
-
Authors
Minoda, Yosuke
Ihara, Eikichi https://orcid.org/0000-0002-7070-6610
Itaba, Soichi
Sumida, Yorinobu
Haraguchi, Kazuhiro
Aso, Akira
Mizutani, Takahiro
Osoegawa, Takashi
Esaki, Mitsuru
Nagatomo, Shuzaburo
Nishioka, Kei
Muta, Kazumasa
Bai, Xiaopeng
Ogino, Haruei
Fujimori, Nao
Tsurumaru, Daisuke
Ohuchida, Kenoki
Qingjiang, Hu
Oki, Eiji
Yamamoto, Hidetaka
Ogawa, Yoshihiro
- License Information
-
More Information
Article History
Received: 27 January 2022
Accepted: 24 June 2022
First Online: 15 July 2022
Declarations
:
: Yosuke Minoda, Soichi Itaba, Yorinobu Sumida, Kazuhiro Haraguchi, Akira Aso, Takahiro Mizutani, Takashi Osoegawa, Mitsuru Esaki, Shuzaburo Nagatomo, Kei Nishioka, Kazumasa Muta, Xiaopeng Bai, Haruei Ogino, Nao Fujimori, Daisuke Tsurumaru, Kenoki Ohuchida, Hu Qingjiang, Eiji Oki, and Hidetaka Yamamoto have no conflict of interest. Eikichi Ihara received lecture fees from Takeda Pharmaceutical Co., Ltd. and belongs to an endowed course supported by the companies, including Ono pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co. Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Fujifilm Medical Co., Ltd., Terumo Corporation, FANCL Corporation, Ohga Pharmacy, and Abbott Japan, LLC. Yoshihito Ogawa conducts collaborative research with Fujifilm Medical Co., Ltd. and FANCL Corporation. The authors declare no other conflicts of interest in association with this study.
